Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-STAR Antibody (R3L89)

Catalog #:   RHE67803 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC
Accession: P49675
Overview

Catalog No.

RHE67803

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Applications

IHC

Recommended Dilution

Application Dilution
IHC 1:100-1:200

Target

STAR, StAR, START domain-containing protein 1, STARD1, Steroidogenic acute regulatory protein, mitochondrial, StARD1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P49675

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3L89

Note

For research use only.

Data Image
  • Immunohistochemical
    IHC-P analysis of adrenal gland tissue by STAR antibody (RHE67803). IHC-P was performed using sections of the formalin-fixed paraffin-embedded adrenal gland tissue;Result: Glandular cells are positively stained at the cytoplasm.
References

Sensitive detection of small extracellular vesicles using a gold nanostar-based SERS assay., PMID:40202797

Protocol to measure the impact of Clostridioides difficile toxins on antibody responses using ELISA, ELISPOT, and toxin-neutralization assays., PMID:40202837

Protocol to study the genomic profile of histone lactylation with CUT&RUN assay in tumor-associated macrophages., PMID:40220301

LRG1 inhibition promotes acute pancreatitis recovery by inducing cholecystokinin Type 1 receptor expression via Akt., PMID:40225588

STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCC., PMID:40248950

Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases., PMID:40262372

SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses., PMID:40266143

Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study)., PMID:40267275

Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study., PMID:40268516

Effects of dietary supplementation with Laurus nobilis extract on growth performance, carcass features, blood lipid profile, immunity, antioxidative status, digestive enzymes, and gut microbial load in growing New Zealand white rabbits., PMID:40272631

Engineering a multi-epitope chimera derived from Acinetobacter baumannii CAM87009.1 and FilF fimbriae proteins: immunogenic and antibiofilm activity., PMID:40274757

Protocol for assessing antibody-dependent cellular phagocytosis by primary murine and human macrophages., PMID:40279242

Differential polyamine metabolism in CHO cell lines: Insights into cell growth and antibody quality., PMID:40287131

Roles of GDF9 and BMP15 in equine follicular development: in vivo content and in vitro effects of IGF1 and cortisol on granulosa cells., PMID:40289073

Permanent Efferocytosis Prevention by Terminating MerTK Recycle on Tumor-Associated Macrophages for Cancer Immunotherapy., PMID:40294287

Alpha-gal syndrome: Recognizing and managing a tick-bite-related meat allergy., PMID:40312115

Protocol for identifying components of subcellular compartments by antibody-based in situ biotinylation., PMID:40315056

Protocol for immunofluorescence characterization of drusen in induced pluripotent stem cell-derived retinal pigment epithelium cultures., PMID:40317724

Protocol for detection of Oropouche viruses from human serum., PMID:40327512

Durvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic non-small-cell lung cancer: outcomes by tumor mutational burden in POSEIDON., PMID:40334315

The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy., PMID:40345181

Protocol for in-plate staining of clinical peripheral blood mononuclear cell samples for high-throughput analysis via spectral flow cytometry., PMID:40347474

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis., PMID:40348635

A Self-Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple-Negative Breast Cancer Therapy., PMID:40349150

Acoustic percolation switches enable targeted drug delivery controlled by diagnostic ultrasound., PMID:40366696

Natural antibodies as frontline helpers in bacterial clearance., PMID:40372771

[Construction of a diagnostic prediction model for childhood allergic asthma based on the detection results of specific IgE for airborne allergens]., PMID:40374356

Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial., PMID:40389374

A Targeted Integration-Based CHO Cell Platform for Simultaneous Antibody Display and Secretion., PMID:40407690

PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases., PMID:40410189

IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesity., PMID:40413022

Protocol for detecting peptide hormones in mosquito tissues., PMID:40413747

Immunocytokines and cytokine neutralization for cancer immunotherapy., PMID:40425444

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition., PMID:40426267

The role of periostin (OSF-2) in the cytoadherence phenomena mediated by malaria parasites., PMID:40433670

Nanobody-Directed CEA-targeting CAR T Cells Eliminate Gastrointestinal Cancer Xenografts., PMID:40439687

Protocol for detecting SnRK2 kinase activity in plants by immunoblotting, in-gel assay, band shift, and immunoprecipitation., PMID:40440176

Effective CAR T-cell targeting of an MUC1 cleavage product., PMID:40447312

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial., PMID:40450142

Application and concentration selection of dithiothreitol for correcting false elevation of D-dimer., PMID:40458086

Protocol for culture, purification, and target validation of a hybridoma-generated monoclonal antibody targeting Aβ truncated species., PMID:40465455

Duchenne muscular dystrophy with Kocher-Debre-Semelaigne syndrome: a double jeopardy., PMID:40466673

Protocol for assessing regional pathology in the rodent optic nerve using longitudinal cryosections and cross-sectional electron microscopy., PMID:40471791

Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial., PMID:40473449

Development and in vitro characterization of humanized antibodies for blocking human TRPM4 channel., PMID:40473754

Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial., PMID:40480650

Protocol for genetic dissection of class switch recombination using genome-editing tools., PMID:40482035

The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine design., PMID:40490475

Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma., PMID:40518441

Lipid Modification and Membrane Localization of Proteins in Cell-Free System., PMID:40536220

Datasheet

Document Download

Anti-STAR Antibody (R3L89).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-STAR Antibody (R3L89) [RHE67803]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only